FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lamotrigine Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Cipla Limited (New 09/20/2019)

Company Contact Information:
844-247-5287

Presentation Posting Date Related Information
25 mg bottles of 100 (NDC 69097-148-07) 09/20/2019
25 mg bottles of 500 (NDC NDC 69097-148-12) 09/20/2019
25 mg bottles of 1000 (NDC 69097-148-15) 09/20/2019
100 mg bottles of 100 (NDC 69097-149-07) 09/20/2019
100 mg bottles of 500 (NDC 69097-149-12) 09/20/2019
100 mg bottles of 1000 (NDC 69097-149-15) 09/20/2019
150 mg bottles of 60 (NDC 69097-151-03) 09/20/2019
150 mg bottles of 500 (NDC 69097-151-12) 09/20/2019
150 mg bottles of 1000 (NDC 69097-151-15) 09/20/2019
200 mg bottles of 60 (NDC 69097-152-03) 09/20/2019
200 mg bottles of 500 (NDC 69097-152-12) 09/20/2019
200 mg bottles of 1000 (NDC 69097-152-15) 09/20/2019

Teva Pharmaceuticals (New 10/15/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
100 mg (NDCs 0093-0463-01 and 0093-0463-05) 10/15/2019 This product is being discontinued due to a business decision.
25 mg tablets (NDCs 0093-0032-05 and 0093-0039-01) 12/21/2018 This product discontinuation is a business related decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English